Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Impact of Glycemic Control Strategies on the Progression of Diabetic Peripheral Neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort
Pop‐Busui, Rodica , Lu, Jiang , Brooks, Maria M. , Althouse, Andrew D. , Escobedo, Jorge , Green, Jenifer, Perkins, Bruce A. , Whitehouse, Fred W., Jones, Teresa L.Z. , Group, for the BARI 2D Study, Albert, Stewart Gary , Palumbo, Pasquale J , Group, for the BARI 2D Study, Pop-Busui, Rodica

Diabetes Care | June 12, 2013 | Volume: 36 | Issue: 10 | Pages: 3208-3215

10.2337/dc13-0012 | PMID 23757426 Get It

OBJECTIVEThe Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial demonstrated similar long-term clinical effectiveness of insulin-sensitizing (IS) versus insulin-providing (IP) treatments for type 2 diabetes on cardiovascular outcomes in a cohort with documented coronary artery disease. We evaluated the effects of randomized glycemic control strategy (IS vs. IP) on the prevalence and incidence of diabetic peripheral neuropathy (DPN).RESEARCH DESIGN AND METHODSDPN (defined as Michigan Neuropathy Screening Instrument [MNSI] clinical examination score >2) was assessed at baseline and yearly for 4 years. DPN prevalence and incidence were compared by intention-to-treat modeling by logistic generalized estimating equation models for prevalence and Kaplan-Meier estimates and Cox regression models for incidence rates.RESULTSResults are reported for 2,159 BARI 2D participants (70% males) with valid baseline and at least one follow-up MNSI score (mean age 62 ± 9 years, mean HbA1c 7.7 ± 1.6%, diabetes duration 10 ± 9 years). There were no differences in the prevalence of DPN between the IS and the IP groups throughout the 4 years of follow-up. In 1,075 BARI 2D participants with no DPN at baseline, the 4-year cumulative incidence rate of DPN was significantly lower in the IS (66%) than in the IP (72%) strategy group (P = 0.02), which remained significant after adjusting for the in-trial HbA1c (P = 0.04). In subgroup analyses, IS strategy had a greater benefit in men (hazard ratio 0.75 [99% CI 0.58–0.99], P < 0.01).CONCLUSIONSAmong patients with type 2 diabetes followed for up to 4 years during BARI 2D, a glycemic control therapy with IS significantly reduced the incidence of DPN compared with IP therapy and may add further benefit for men.
Contractile Reserve Determined on Exercise Echocardiography in Patients With Severe Aortic Regurgitation
Enriquez‐Sarano, Maurice , Song, Jung-Eun, Lee, Yung-Joo, Ha, Mi-Ran, Chang, Sung‐A , Choi, Jin‐Oh , Park, Seung Woo , Oh, Jae K. , Park, Sung‐Ji , Lee, Yung-Joo, Lee, Sang‐Chol , Enriquez-Sarano, Maurice

Circulation Journal | June 11, 2013 | Volume: 77 | Issue: 9 | Pages: 2390-2398

10.1253/circj.cj-13-0109 | PMID 23759654 Get It

Cold agglutinin disease
Hegerova, Livia , Swiecicki, Paul L, Swiecicki, Paul Loren , Gertz, Morie A.

Blood | June 11, 2013 | Volume: 122 | Issue: 7 | Pages: 1114-1121

10.1182/blood-2013-02-474437 | PMID 23757733 Get It

Abstract Cold agglutinin disease is a rare and poorly understood disorder affecting 15% of patients with autoimmune hemolytic anemia. We reviewed the clinical and pathologic features, prognosis, and management in the literature and describe our institutional experience to improve strategies for accurate diagnosis and treatment. Retrospective analysis identified 89 patients from our institution with cold agglutinin disease from 1970 through 2012. Median age at symptom onset was 65 years (range, 41 to 83 years), whereas the median age at diagnosis was 72 years (range, 43 to 91 years). Median survival of all patients was 10.6 years, and 68 patients (76%) were alive 5 years after the diagnosis. The most common symptom was acrocyanosis (n = 39 [44%]), and many had symptoms triggered by cold (n = 35 [39%]) or other factors (n = 20 [22%]). An underlying hematologic disorder was detected in 69 patients (78%). Thirty-six patients (40%) received transfusions during their disease course, and 82% received drug therapy. Rituximab was associated with the longest response duration (median, 24 months) and the lowest proportion of patients needing further treatment (55%). Our institution’s experience and review of the literature confirms that early diagnostic evaluation and treatment improves outcomes in cold agglutinin disease.
Adult Ewing Sarcoma: Survival and Local Control Outcomes in 102 Patients with Localized Disease
Robinson, Steven I. , Okuno, Scott H. , Rose, Peter S. , Ahmed, Safia K. , Laack, Nadia N. , Robinson, Steven I

Sarcoma | June 11, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-7

10.1155/2013/681425 | PMID 23840168 Get It

Objectives. To assess the clinical features and local control (LC) outcomes in adult patients with localized Ewing Sarcoma (ES).Methods. The records of 102 ES patients with localized disease ≥18 years of age seen from 1977 to 2007 were reviewed. Factors relevant to prognosis, survival, and LC were analyzed.Results.The 5-year overall survival (OS) and event-free survival (EFS) were 60% and 52%, respectively, for the entire cohort. Treatment era (1977–1992 versus 1993–2007) remained an independent prognostic factor for OS on multivariate analysis, with improved outcomes observed in the 1993–2007 era (P=0.02). The 5-year OS and EFS for the 1993–2007 era were 73% and 60%, respectively. Ifosfamide and etoposide based chemotherapy and surgery were more routinely used in the 1993–2007 era (P<0.01). The 5-year local failure rate (LFR) was 14%, with a 5-year LFR of 18% for surgery, 33% for radiation, and 0% for combined surgery and radiation in the 1993–2007 era (P=0.17).Conclusion. Modern survival outcomes for adults with localized ES are similar to multi-institutional results in children. This improvement over time is associated with treatment intensification with chemotherapy and increased use of surgery. Aggressive LC (combined surgery and radiation) may improve outcomes in poor prognosis patients.
The Science and Ethics of Withdrawing Mechanical Positive Pressure Ventilatory Support in the Terminally Ill
Rady, Mohamed Y. , Verheijde, Joseph L.

Journal of Palliative Medicine | June 11, 2013 | Volume: 16 | Issue: 8 | Pages: 828-830

10.1089/jpm.2013.0166 | PMID 23758501 Get It

Simulation training for breast and pelvic physical examination: a systematic review and meta‐analysis
Dilaveri, CA, Szostek, JH, Wang, AT, Cook, DA

BJOG: An International Journal of Obstetrics & Gynaecology | June 11, 2013 | Volume: 120 | Issue: 10 | Pages: 1171-1182

10.1111/1471-0528.12289 | PMID 23750657 Get It

BackgroundBreast and pelvic examinations are challenging intimate examinations. Technology‐based simulation may help to overcome these challenges.ObjectiveTo synthesise the evidence regarding the effectiveness of technology‐based simulation training for breast and pelvic examination.Search strategyOur systematic search included MEDLINE, EMBASE, CINAHL, PsychINFO, Scopus, and key journals and review articles; the date of the last search was January 2012.Selection criteriaOriginal research studies evaluating technology‐enhanced simulation of breast and pelvic examination to teach learners, compared with no intervention or with other educational activities.Data collection and analysisThe reviewers evaluated study eligibility and abstracted data on methodological quality, learners, instructional design, and outcomes, and used random‐effects models to pool weighted effect sizes.Main resultsIn total, 11 272 articles were identified for screening, and 22 studies were eligible, enrolling 2036 trainees. In eight studies comparing simulation for breast examination training with no intervention, simulation was associated with a significant improvement in skill, with a pooled effect size of 0.86 (95% CI 0.52–1.19; P < 0.001). Four studies comparing simulation training for pelvic examination with no intervention had a large and significant benefit, with a pooled effect size of 1.18 (95% CI 0.40–1.96; P = 0.003). Among breast examination simulation studies, dynamic models providing feedback were associated with improved outcomes. In pelvic examination simulation studies, the addition of a standardised patient to the simulation model and the use of an electronic model with enhanced feedback improved outcomes.Author's conclusionsIn comparison with no intervention, breast and pelvic examination simulation training is associated with moderate to large effects for skills outcomes. Enhanced feedback appears to improve learning.
Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide
Boerwinkle, Eric , O’Connell, Jeffrey R. , Bailey, Kent R. , Chapman, Arlene B. , McDonough, Caitrin W. , Beitelshees, Amber L. , Schwartz, Gary L. , Gums, John G. , Padmanabhan, Sandosh , Hiltunen, Timo P. , Citterio, Lorena , Donner, Kati , Hedner, Thomas, Lanzani, Chiara , Melander, Olle , Saarela, Janna , Wahlstrand, Björn, Manunta, Paolo , Kontula, Kimmo , Dominiczak, Anna F. , Johnson, Julie A. , Beitelshees, Amber L. , Turner, Stephen T. , Gong, Yan , Chapman, Arlene B. , Ripatti, Samuli , Cooper‐DeHoff, Rhonda M. , Padmanabhan, Sandosh , Dominiczak, Anna F.

Hypertension | June 11, 2013 | Volume: 62 | Issue: 2 | Pages: 391-397

10.1161/hypertensionaha.111.00436 | PMID 23753411 Get It

To identify novel genes influencing blood pressure response to thiazide diuretic therapy for hypertension, we conducted genome-wide association meta-analyses of ≈1.1 million single-nucleotide polymorphisms in a combined sample of 424 European Americans with primary hypertension treated with hydrochlorothiazide from the Pharmacogenomic Evaluation of Antihypertensive Responses study (n=228) and the Genetic Epidemiology of Responses to Antihypertensive study (n=196). Polymorphisms associated with blood pressure response at P <10 –5 were tested for replication of the associations in independent samples of hydrochlorothiazide-treated European hypertensives. The rs16960228 polymorphism in protein kinase C, α replicated for same-direction association with diastolic blood pressure response in the Nordic Diltiazem study (n=420) and the Genetics of Drug Responsiveness in Essential Hypertension study (n=206), and the combined 4-study meta-analysis P value achieved genome-wide significance ( P =3.3×10 −8 ). Systolic or diastolic blood pressure responses were consistently greater in carriers of the rs16960228 A allele than in GG homozygotes (>4/4 mm Hg) across study samples. The rs2273359 polymorphism in the GNAS-EDN3 region also replicated for same-direction association with systolic blood pressure response in the Nordic Diltiazem study, and the combined 3-study meta-analysis P value approached genome-wide significance ( P =5.5×10 −8 ). The findings document clinically important effects of genetic variation at novel loci on blood pressure response to a thiazide diuretic, which may be a basis for individualization of antihypertensive drug therapy and identification of new drug targets.
Vascular Access Site Injury After Transfemoral Transcatheter Aortic Valve Insertion
Greason, Kevin L. , Suri, Rakesh M. , Huebner, Marianne , Reeder, Guy S., Williamson, Eric E. , Rihal, Charanjit S. , Mathew, Verghese, Nkomo, Vuyisile T. , Rihal, Charanjit S.

Journal of Cardiac Surgery | June 11, 2013 | Volume: 28 | Issue: 4 | Pages: 348-352

10.1111/jocs.12140 | PMID 23750934 Get It

Online Problem-Solving Therapy for Executive Dysfunction After Child Traumatic Brain Injury
Kurowski, Brad G. , Wade, Shari L. , Kirkwood, Michael W. , Brown, Tanya M. , Stancin, Terry , Taylor, Hudson Gerry

Pediatrics | June 11, 2013 | Volume: 132 | Issue: 1 | Pages: e158-e166

10.1542/peds.2012-4040 | PMID 23753094 Get It

OBJECTIVE: Executive dysfunction after traumatic brain injury (TBI) in children is common and leads to significant problems in functioning across multiple settings. The objective of this study was to evaluate the efficacy of a web-based counselor-assisted problem solving (CAPS) intervention compared with an Internet resource comparison (IRC) for treatment of executive dysfunction within 12 months after complicated mild to severe TBI in adolescents. We hypothesized that CAPS would significantly improve parent ratings of executive dysfunction compared with an IRC. METHODS: Participants included 132 adolescents aged 12 to 17 years who sustained a complicated mild to severe TBI within 1 to 6 months before study enrollment. Study design was a multisite, assessor-blinded, randomized controlled trial. Study sites included 3 tertiary pediatric hospitals and 2 tertiary general medical centers. The main outcome measure was primary caregiver Behavioral Rating Inventory of Executive Function Global Executive Composite at baseline and 6-month follow-up. Generalized linear models that controlled for baseline scores were used to compare the CAPS and IRC scores. RESULTS: In older teens, the CAPS group showed significant improvement in executive function behaviors at 6-month follow-up compared with the IRC group (F = 6.74, P = .01, Cohen’s d = 0.63). CONCLUSIONS: Findings indicate that web-based CAPS improves primary caregiver-rated executive functioning within the first 12 months after TBI in older adolescents. Future research needs to define the optimal timing after injury for delivery of CAPS and characteristics of individuals and families who are most likely to benefit from CAPS.